EGFR and HER2 mutation and gene amplification in non-small-cell lung cancer

被引：0
|
作者：
Toshihiko, Yokoyama
Kondo, Masashi
Goto, Yasuhiro
Fukui, Takayuki
Yoshioka, Hiromu
Yokoi, Kohei
Kondo, Yutaka
Osada, Hirotaka
Imaizumi, Kazuyoshi
Hasegawa, Yoshinori
Shimokata, Kaoru
Sekido, Yoshitaka
机构：
[1] Aichi Canc Ctr, Nagoya, Aichi, Japan
[2] Nagoya Univ, Dept Resp Med, Nagoya, Aichi, Japan
[3] Nagoya Univ, Dept Thorat Surg, Nagoya, Aichi, Japan
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4134
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [21] EGFR and HER2/NEU in gefitinib chemotherapy for non-small cell lung cancer
    Yoo, J.
    HISTOPATHOLOGY, 2008, 53 : 406 - 406
  • [22] The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung Cancer
    Nagasaka, Misako
    Singh, Vijendra
    Baca, Yasmine
    Sukari, Ammar
    Kim, Chul
    Mamdani, Hirva
    Spira, Alexander, I
    Uprety, Dipesh
    Bepler, Gerold
    Kim, Edward S.
    Raez, Luis E.
    Pai, Sachin Gopalkrishna
    Ikpeazu, Chukwuemeka
    Oberley, Matthew
    Feldman, Rebecca
    Xiu, Joanne
    Korn, W. Michael
    Wozniak, Antoinette J.
    Borghaei, Hossein
    Liu, Stephen, V
    CLINICAL LUNG CANCER, 2022, 23 (01) : 52 - 59
  • [23] Relationship between PD-L1 Expression and EGFR/HER2 Signaling in Non-Small-Cell Lung Cancer
    Okita, R.
    Maeda, A.
    Shimizu, K.
    Nojima, Y.
    Saisho, S.
    Nakata, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2109 - S2109
  • [24] Non-Small-Cell Lung Cancer with HER2 Exon 20 Mutation Regression with Dual HER2 Inhibition and Anti-VEGF Combination Treatment
    Falchook, Gerald S.
    Janku, Filip
    Tsao, Anne S.
    Bastida, Christel C.
    Stewart, David J.
    Kurzrock, Razelle
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (02) : E19 - E20
  • [25] EGFR Mutation in Non-Small Cell Lung Cancer is Influenced by EGFR Amplification and Biomarkers
    Pollen, M.
    Waterman, J. P.
    Ding, M.
    Alvarez, A.
    Boyd, M.
    Streifel, J.
    Noroberg, M. L.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06): : 655 - 655
  • [26] Concomitant EGFR Mutation and ALK Rearrangement in Non-Small-Cell Lung Cancer
    Chen, R.
    Zhang, X.
    Wu, Y.
    Chen, H.
    Zhou, Q.
    Su, J.
    Tu, H.
    Xie, Z.
    Zhong, W.
    Yang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2225 - S2226
  • [27] Metastatic non-small-cell lung cancer with EGFR mutation - case report
    Jasiowka, Marek
    Cedrych, Ida
    ONCOLOGY IN CLINICAL PRACTICE, 2014, 10 : G46 - G48
  • [28] Double mutation and gene copy number of EGFR in gefitinib refractory non-small-cell lung cancer
    Tokumo, Masaki
    Toyookaa, Shinichi
    Ichihara, Shuji
    Ohashi, Kadoaki
    Tsukuda, Kazunori
    Ichimura, Kouichi
    Tabata, Masahiro
    Kiura, Katsuyuki
    Aoe, Motoi
    Sano, Yoshifumi
    Date, Hiroshi
    Shimizu, Nobuyoshi
    LUNG CANCER, 2006, 53 (01) : 117 - 121
  • [29] HER2 AND BRAF MUTATIONS IN NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS (P)
    Estival, Anna
    Carcereny, Enric
    Indacochea, Alberto
    Luis Ramirez, Jose
    Moran, Teresa
    Luis Cuadra, Jose
    Vila, Laia
    Gil, Maria
    Botia, Monica
    Perez, M.
    Tierno, M.
    Capdevila, Laia
    Rosell, Rafael
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S957 - S957
  • [30] EGFR mutation and non-small-cell lung cancer: EGFR test, cost and quality of life
    Thongprasert, Sumitra
    LUNG CANCER MANAGEMENT, 2012, 1 (03) : 169 - 172
12345